PLERIXAFOR INJECTION
Dr Reddy's plunges nearly 2% on patent infringement suitDr Reddy's Laboratories plunged as much as 1.85% in a weak market on Monday after Genzyme Corporation filed a suit against the company.23 Sep, 2013, 10.00 AM IST
Genzyme Corporation files patent infringement suit against DRLMozobil (plerixafor injection) is a hematopoietic stem cell mobiliser indicated to patients with non-Hodgkin's lymphoma (blood cancer) and ...22 Sep, 2013, 01.30 PM IST
Load More